The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Targeting neuroinflammation in Alzheimer’s disease
Open accessAbstract
Almost 47 million people suffer from dementia worldwide, with an estimated new case diagnosed every 3.2 seconds. Alzheimer's disease (AD) accounts for approximately 60%-80% of all dementia cases. Given this evidence, it is clear dementia represents one of the greatest global public health challenges. Currently used drugs alleviate the symptoms of AD but do not treat the underlying causes of dementia. Hence, a worldwide quest is under way to find new treatments to stop, slow, or even prevent AD. Besides the classic targets of the oldest therapies, represented by cholinergic and glutamatergic systems, β-amyloid (Aβ) plaques, and tau tangles, new therapeutic approaches have other targets. One of the newest and most promising strategies is the control of reactive gliosis, a multicellular response to brain injury. This phenomenon occurs as a consequence of a persistent glial activation, which leads to cellular dysfunctions and neuroinflammation. Reactive gliosis is now considered a key abnormality in the AD brain. It has been demonstrated that reactive astrocytes surround both Aβ plaques and tau tangles. In this condition, glial cells lose some of their homeostatic functions and acquire a proinflammatory phenotype amplifying neuronal damage. So, molecules that are able to restore their physiological functions and control the neuroinflammatory process offer new therapeutic opportunities for this devastating disease. In this review, we describe the role of neuroinflammation in the AD pathogenesis and progression and then provide an overview of the recent research with the aim of developing new therapies to treat this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
(2015) · HAL · Cited by 2,238
Tripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 1×
“pattern recognition receptors able to induce inflammatory signaling pathways.(13) These pattern recognition receptors can recognize molecular signals of microbial molecules, called pathogen-associated molecular patterns, as well as endogenous damage-associated molecular patterns (DAMPs), that typically accumulate in i…”
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Glial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 1×
“47,48 49–51 The resulting chronic inflammation is due to the release of proinflammatory molecules that act not only in an autocrine manner, allowing the perpetuation of the reactive gliosis, but also in a paracrine one, the main cause of the neuronal death that increases the pathological damage.”
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Sofroniew, M. V. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020420 · Cited by 695
Microglia derived from aging mice exhibit an altered inflammatory profile
Sierra, A., Gottfried‐Blackmore, A. C., McEwen, B. S., & Bulloch, K. (2007) · Glia · doi:10.1002/glia.20468 · Cited by 688
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 601
Lian, H., Litvinchuk, A., Chiang, A. C.-A., Aithmitti, N., Jankowsky, J. L., & Zheng, H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2117-15.2016 · Cited by 597
Baum, L., Lam, C. W. K., Cheung, S. K.-K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 592
Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584
Resolving postoperative neuroinflammation and cognitive decline
Terrando, N., Eriksson, L. I., Kyu Ryu, J., Yang, T., Monaco, C., Feldmann, M., Jonsson Fagerlund, M., Charo, I. F., Akassoglou, K., & Maze, M. (2011) · Annals of Neurology · doi:10.1002/ana.22664 · Cited by 579
Olabarria, M., Noristani, H. N., Verkhratsky, A., & Rodríguez, J. J. (2010) · Glia · doi:10.1002/glia.20967 · Cited by 499
Newly generated neurons in the amygdala and adjoining cortex of adult primates
Bernier, P. J., Bédard, A., Vinet, J., Lévesque, M., & Parent, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172403999 · Cited by 478
Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100620 · Cited by 473
Bouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460
The microglial "activation" continuum: from innate to adaptive responses
Town, T., Nikolic, V., & Tan, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-24 · Cited by 456
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Witte, A. V., Kerti, L., Margulies, D. S., & Floel, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0385-14.2014 · Cited by 455
Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
Koenigsknecht, J., & Landreth, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 446
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438
Chen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000149 · Cited by 433
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388
Rofecoxib: No effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B. A., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 385
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Vezzani, A., Maroso, M., Balosso, S., Sanchez, M.-A., & Bartfai, T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.018 · Cited by 362
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Ferreira, S. T., Clarke, J. R., Bomfim, T. R., & De Felice, F. G. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.010 · Cited by 356
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group (2007) · Neurology · doi:10.1212/01.wnl.0000260269.93245.d2 · Cited by 354
S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes
Hu, J., Ferreira, A., & Van Eldik, L. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062294.x · Cited by 336
Extended results of the Alzheimer's disease anti‐inflammatory prevention trial
Breitner, J. C., Baker, L. D., Montine, T. J., Meinert, C. L., Lyketsos, C. G., Ashe, K. H., Brandt, J., Craft, S., Evans, D. E., Green, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.014 · Cited by 328
Batsch, N., & Mittelman, M. S. (2012) · Cited by 325
Jiang, T., Tan, L., Zhu, X.-C., Zhang, Q.-Q., Cao, L., Tan, M.-S., Gu, L.-Z., Wang, H.-F., Ding, Z.-Z., Zhang, Y.-D., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.164 · Cited by 320
pH regulation and proton signalling by glial cells
Deitmer, J. W., & Rose, C. R. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00039-9 · Cited by 296
Microglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291
Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288
Role of RAGE in Alzheimer’s Disease
Cai, Z., Liu, N., Wang, C., Qin, B., Zhou, Y., Xiao, M., Chang, L., Yan, L.-J., & Zhao, B. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0233-3 · Cited by 285
Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B., & Hofman, A. (1995) · Neurology · doi:10.1212/wnl.45.8.1441 · Cited by 285
Jaeger, L. B., Dohgu, S., Sultana, R., Lynch, J. L., Owen, J. B., Erickson, M. A., Shah, G. N., Price, T. O., Fleegal-Demotta, M. A., Butterfiled, D. A., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.01.017 · Cited by 281
Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277
Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
Zotova, E., Bharambe, V., Cheaveau, M., Morgan, W., Holmes, C., Harris, S., Neal, J. W., Love, S., Nicoll, J. A. R., & Boche, D. (2013) · Brain · doi:10.1093/brain/awt210 · Cited by 272
Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J.-L., Murphy, P. M., Oppenheim, J. J., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 270
Walker, D. G., Dalsing-Hernandez, J. E., Campbell, N. A., & Lue, L.-F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.003 · Cited by 267
Wong, D., Dorovini-Zis, K., & Vincent, S. R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.008 · Cited by 264
Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders
Von Bernhardi, R., Tichauer, J. E., & Eugenín, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06537.x · Cited by 258
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00293-7 · Cited by 248
Microglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
Xu, P.-X., Wang, S.-W., Yu, X.-L., Su, Y.-J., Wang, T., Zhou, W.-W., Zhang, H., Wang, Y.-J., & Liu, R.-T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.002 · Cited by 232
Gasparini, L., Ongini, E., & Wenk, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02743.x · Cited by 226
Nitric oxide and nitroxidative stress in Alzheimer's disease
Malinski, T. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11208 · Cited by 220
Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines
Alam, Q., Zubair Alam, M., Mushtaq, G., A. Damanhouri, G., Rasool, M., Amjad Kamal, M., & Haque, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151125000300 · Cited by 220
Shi, J.-Q., Shen, W., Chen, J., Wang, B.-R., Zhong, L.-L., Zhu, Y.-W., Zhu, H.-Q., Zhang, Q.-Q., Zhang, Y.-D., & Xu, J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.053 · Cited by 219
Vogl, T., Gharibyan, A. L., & Morozova-Roche, L. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13032893 · Cited by 211
Mori, T., Koyama, N., Arendash, G. W., Horikoshi‐Sakuraba, Y., Tan, J., & Town, T. (2010) · Glia · doi:10.1002/glia.20924 · Cited by 205
Verkhratsky, A., Nedergaard, M., & Hertz, L. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1403-2 · Cited by 205
Tweedie, D., Ferguson, R. A., Fishman, K., Frankola, K. A., Van Praag, H., Holloway, H. W., Luo, W., Li, Y., Caracciolo, L., Russo, I., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-106 · Cited by 204
Neuroinflammatory phenotype in early Alzheimer's disease
Sudduth, T. L., Schmitt, F. A., Nelson, P. T., & Wilcock, D. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.012 · Cited by 195
Braak, H., & Braak, E. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90032-9 · Cited by 181
Venigalla, M., Sonego, S., Gyengesi, E., Sharman, M. J., & Münch, G. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.011 · Cited by 175
Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits
Jiao, S.-S., Yao, X.-Q., Liu, Y.-H., Wang, Q.-H., Zeng, F., Lu, J.-J., Liu, J., Zhu, C., Shen, L.-L., Liu, C.-H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422998112 · Cited by 174
TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
Otero, K., Shinohara, M., Zhao, H., Cella, M., Gilfillan, S., Colucci, A., Faccio, R., Ross, F. P., Teitelbaum, S. L., Takayanagi, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102836 · Cited by 171
Welser-Alves, J. V., & Milner, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.04.007 · Cited by 169
Glial influences on BBB functions and molecular players in immune cell trafficking
Lécuyer, M.-A., Kebir, H., & Prat, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.004 · Cited by 163
Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease
Shepherd, C. E., Goyette, J., Utter, V., Rahimi, F., Yang, Z., Geczy, C. L., & Halliday, G. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.033 · Cited by 161
The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade
Wang, C., Klechikov, A. G., Gharibyan, A. L., Wärmländer, S. K. T. S., Jarvet, J., Zhao, L., Jia, X., Shankar, S. K., Olofsson, A., Brännström, T., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1208-4 · Cited by 156
Why Pleiotropic Interventions are Needed for Alzheimer's Disease
Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 153
de Jong, D., Jansen, R. W. M. M., Hoefnagels, W. H. L., Mj, J.-E., Verbeek, M. M., Borm, G. F., & Kremer, B. P. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001475 · Cited by 151
Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease
von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugenín, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00426 · Cited by 149
Astrogliopathology: A Central Element of Neuropsychiatric Diseases?
Verkhratsky, A., Rodriguez, J. J., & Steardo, L. (2013) · The Neuroscientist · doi:10.1177/1073858413510208 · Cited by 149
Self-citationThe role of astrocytes in amyloid β-protein toxicity and clearance
Thal, D. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.021 · Cited by 146
Liu, Y., Lin, H.-I., & Tzeng, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.085 · Cited by 136
Melchior, B., Garcia, A., Hsiung, B., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN NEURO · doi:10.1042/an20100010 · Cited by 136
Liu, X., Wu, Z., Hayashi, Y., & Nakanishi, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.050 · Cited by 134
Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133
Huang, W., Lin, Y., Wang, C., Tsai, C., Tseng, H., Chen, C., Lu, P., Chen, P. S., Li, Q., Hong, J., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02959.x · Cited by 130
Wang, M.-J., Huang, H., Chen, W.-F., Chang, H., & Kuo, J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-99 · Cited by 119
GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
Green, H. F., & Nolan, Y. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.003 · Cited by 117
Imaging of neuroinflammation in dementia: a review
Stefaniak, J. D., & O'Brien, J. T. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311336 · Cited by 115
Genomic structure, induction, and production of TNF-alpha.
Spriggs, D. R., Deutsch, S., & Kufe, D. W. (1992) · PubMed · Cited by 107
Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
Garwood, C. J., Cooper, J. D., Hanger, D. P., & Noble, W. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00136 · Cited by 106
Scuderi, C., Stecca, C., Valenza, M., Ratano, P., Bronzuoli, M. R., Bartoli, S., Steardo, L., Pompili, E., Fumagalli, L., Campolongo, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.376 · Cited by 106
Self-citationParachikova, A. I., Vasilevko, V., Cribbs, D. H., LaFerla, F. M., & Green, K. N. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100204 · Cited by 104
Oridonin Attenuates Aβ1–42-Induced Neuroinflammation and Inhibits NF-κB Pathway
Wang, S., Yang, H., Yu, L., Jin, J., Qian, L., Zhao, H., Xu, Y., & Zhu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104745 · Cited by 103
Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology
Rosenberger, A. F. N., Morrema, T. H. J., Gerritsen, W. H., van Haastert, E. S., Snkhchyan, H., Hilhorst, R., Rozemüller, A. J. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0470-x · Cited by 100
Lyons, A., McQuillan, K., Deighan, B. F., O’Reilly, J.-A., Downer, E. J., Murphy, A. C., Watson, M., Piazza, A., O’Connell, F., Griffin, R., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.05.060 · Cited by 98
Complexities of targeting innate immunity to treat infection
Brown, K. L., Cosseau, C., Gardy, J. L., & Hancock, R. E. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.04.005 · Cited by 98
Esposito, G., Scuderi, C., Lu, J., Savani, C., Filippis, D. D., Iuvone, T., Steardo, L., Jr., Sheen, V. L., & Steardo, L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00159.x · Cited by 97
Self-citationYin and Yang: complement activation and regulation in Alzheimer’s disease
Shen, Y., & Meri, S. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.08.001 · Cited by 92
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s disease
Cantarella, G., Benedetto, G. D., Puzzo, D., Privitera, L., Loreto, C., Saccone, S., Giunta, S., Palmeri, A., & Bernardini, R. (2014) · Brain · doi:10.1093/brain/awu318 · Cited by 90
Cirillo, C., Capoccia, E., Iuvone, T., Cuomo, R., Sarnelli, G., Steardo, L., & Esposito, G. (2015) · BioMed Research International · doi:10.1155/2015/508342 · Cited by 89
Self-citationEngelhardt, B. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2010.009.x · Cited by 87
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
Steardo, L., Bronzuoli, M. R., Iacomino, A., Esposito, G., Steardo, L., & Scuderi, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00259 · Cited by 82
Self-citationMoving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
Castello, M. A., Jeppson, J. D., & Soriano, S. (2014) · BMC Neurology · doi:10.1186/s12883-014-0169-0 · Cited by 80
Varnum, M. M., Kiyota, T., Dixie, K. L. I., Ikezu, S., & Ikezu, T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.027 · Cited by 77
He, P., Cheng, X., Staufenbiel, M., Li, R., & Shen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055091 · Cited by 76
Microglia as Dynamic and Essential Components of the Amyloid Hypothesis
Gandy, S., & Heppner, F. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.007 · Cited by 74
The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease
Fava, A., Pirritano, D., Plastino, M., Cristiano, D., Puccio, G., Colica, C., Ermio, C., Bartolo, M. D., Mauro, G. F., & Bosco, D. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/454253 · Cited by 71
Feld, M., Krawczyk, M., Fustiñana, M. S., Blake, M., Baratti, C., Romano, A., & Boccia, M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131076 · Cited by 70
Casamenti, F., Grossi, C., Rigacci, S., Pantano, D., Luccarini, I., & Stefani, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142850 · Cited by 69
Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
Scuderi, C., Stecca, C., Bronzuoli, M. R., Rotili, D., Valente, S., Mai, A., & Steardo, L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00089 · Cited by 69
Self-citationAstrocyte modulation of in vitro β‐amyloid neurotoxicity
Paradisi, S., Sacchetti, B., Balduzzi, M., Gaudi, S., & Malchiodi‐Albedi, F. (2004) · Glia · doi:10.1002/glia.20005 · Cited by 68
Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.003 · Cited by 62
The Chemerin Receptor CMKLR1 is a Functional Receptor for Amyloid-β Peptide
Lei, P., Yu, Y., Liu, J., Li, S., He, H., Cheng, N., & Ye, R. D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141227 · Cited by 60
Song, Y., Cui, T., Xie, N., Zhang, X., Qian, Z., & Liu, J. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.03.006 · Cited by 58
Anti-inflammatory effects of glaucocalyxin B in microglia cells
Gan, P., Li, Z., Chen, Y., Zhang, Y., Zhang, F., Zhou, X., Zhang, X., Gao, B., Zhen, X., Zhang, J., et al. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.04.005 · Cited by 57
Christov, A. M., Ottman, J. T., & Grammas, P. (2004) · Neurological Research · doi:10.1179/016164104225016218 · Cited by 54
Mathur, R., Ince, P. G., Minett, T., Garwood, C. J., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., Wharton, S. B., & on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · PLOS ONE · doi:10.1371/journal.pone.0118463 · Cited by 52
Role of astrocytes in major neurological disorders: The evidence and implications
Scuderi, C., Stecca, C., Iacomino, A., & Steardo, L. (2013) · IUBMB Life · doi:10.1002/iub.1223 · Cited by 49
Self-citationScuderi, C., & Steardo, L. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010011 · Cited by 46
Self-citationPredicting cognitive decline in Alzheimer's disease: An integrated analysis
López, O. L., Schwam, E. M., Cummings, J. L., Gauthier, S. G., Jones, R. W., Wilkinson, D. G., Waldemar, G., Zhang, R. H., & Schindler, R. J. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.04.003 · Cited by 43
Czapski, G. A., Gąssowska-Dobrowolska, M., Wilkaniec, A., Chalimoniuk, M., Strosznajder, J. B., & Adamczyk, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.01.005 · Cited by 39
Li, K., Liu, S., Yao, S., Wang, B., Dai, D., & Yao, L. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000204766 · Cited by 37
B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition
Bicca, M. A., da Costa, R., Loch-Neckel, G., Figueiredo, C. P., Medeiros, R., & Calixto, J. Β. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.040 · Cited by 32
Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients
Yu, S., Liu, Y., Liu, Y.-H., Jiao, S., Liu, L., Wang, Y., & Fu, W. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.12.018 · Cited by 28
Positive and negative effects of prostaglandins in A lzheimer's disease
Fattahi, M. J., & Mirshafiey, A. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12092 · Cited by 27
Counts, S., Ray, B., Mufson, E. J., Perez, S. E., He, B., & Lahiri, D. K. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0020-9 · Cited by 24
The role of the TLR4/NF-κB signaling pathway in Aβ accumulation in primary hippocampal neurons.
Wu, D., Zhang, X., Zhao, M., & Zhou, A. (2015) · PubMed · Cited by 19
Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?
Pohanka, M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114733 · Cited by 13
FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
Wu, L.-Y., Bao, X.-Q., Pang, H.-Y., Sun, H., & Zhang, D. (2015) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2014.1003183 · Cited by 9
Martin, B. K., Szekely, C., Brandt, J., Piantadosi, S., Breitner, J. C., Craft, S., Evans, D. A., Green, R. C., & Mullan, M. (2008) · eScholarship (California Digital Library) · Cited by 8
Xing, X., Zhang, W., Sha, S., Li, Y., Guo, R., Cai, W., & Cao, Y.-P. (2011) · PubMed · Cited by 7
Cited by
Nagpal, R., Neth, B. J., Wang, S., Craft, S., & Yadav, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.032 · Cited by 653
Sochocka, M., Donskow-Łysoniewska, K., Diniz, B. S., Kurpas, D., Brzozowska, E., & Leszek, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1188-4 · Cited by 584
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Dhapola, R., Hota, S. S., Sarma, P., Bhattacharyya, A., Medhi, B., & Reddy, D. H. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00889-6 · Cited by 383
Metadata
- Authors
- Bronzuoli, M. R., Iacomino, A., Steardo, L., & Scuderi, C.
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2016-11
- Volume
- Volume 9
- Pages
- 199-208
- ISSN
- 1178-7031 (ISSN-L)
- OpenAlex
- W2548821687
- Cited by
- 255
- References
- 148
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.